NCT05782270View on ClinicalTrials.gov

Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
AnticoagulationCoronary Endarterectomy
Interventions
DRUG

Warfarin

dual antiplatelet therapy combined with warfarin

DRUG

DAPT

Dual antiplatelet therapy (aspirin plus either clopidogrel or ticagrelor)

OTHER

CE+CABG

Coronary endarterectomy combined with coronary artery bypass grafting

Trial Locations (1)

100037

RECRUITING

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV